Facebook link Linked In link You Tube link

Advanced Course in Basic & Clinical Immunology

Advanced Course in Basic and Clinical Immunology

Advanced Course in Basic & Clinical Immunology

February 19-22, 2017
FireSky Resort & Spa
Scottsdale, Arizona 

Registration Opens: October 2016

Course Directors

pillai-shiv Laufer2
Shiv Pillai, MD, PhD
Massachusetts General Hospital
Terri Laufer, MD
University of Pennsylvania

Quick Links

Course Description

Invited speakers are chosen based on their expertise in basic and clinical immunology, as well as their teaching skills. The lectures cover the major topics in cellular and molecular immunology, including innate immunity, B cells, T cells, dendritic cells, cytokines and mucosal immunity. Other lectures cover autoimmune, allergic and immunodeficiency diseases, as well as new advances in interventional and clinical immunology and the molecular and genetic basis of immunologically-mediated diseases. All lecturers encourage interaction with the students through questions and discussions during lecture time. There is also ample opportunity for students to interact with the faculty outside the lecture room.

Target Audience

The target audience includes clinical fellows in disciplines related to immunology, including rheumatology, allergy, infectious disease, oncology and transplantation; fellows doing basic research with an emphasis on human disease; scientists or other research and development personnel from biotechnology and pharmaceutical companies who are involved in developing new therapies for immunological disease; and academic or community physicians who wish to enhance their understanding of immunology.

Course Objectives

At the conclusion of this course, attendees will be able to:

  • Discuss the fundamental mechanisms underlying protective immune responses, and discuss the recent advances and emerging themes in immunology research.
  • Describe the fundamental mechanisms underlying immunologic disease and associate these mechanisms with strategies for therapeutic modulation of the immune system.
  • Appreciate the basic immunological principles underlying biotherapeutics, recognize the commonality among diverse organ-specific disease states and infer the mechanisms of therapeutic effect.
  • Analyze the medical literature reporting immunologic advances pertinent to their patients, cite the rationale for use of new immunodiagnostic and immunotherapeutic modalities in their patients, and serve as thought leaders within their medical communities.

Preliminary Program

Sunday February 19
5:00-7:00 pm Welcome Reception and Registration
Monday  February 20
8:00-8:30 am Continental Breakfast
8:30-9:00 am Overview of the Immune System - Shiv Pillai, MD, PhD, Massachusetts General Hospital
9:00-10:00 am Innate Immunity (Molecules) - Stephanie Eisenbarth, MD, PhD, Yale University
10:00-10:15 am Break
10:15-11:15 am Antigen Presentation - Kenneth Rock, MD, University of Massachusetts
11:15-11:30 am Break
11:30 am - 12:30 pm Antibodies and Disease - Shiv Pillai, MD, PhD, Massachusetts General Hospital
12:30-1:30 pm Lunch
1:30-2:30 pm Innate Immunity (Cells) - Stephanie Eisenbarth, MD, PhD, Yale University
2:30-2:45 pm Break
2:45-3:45 pm T Cell Activation - Abul Abbas, MD, University of California, San Francisco 
3:45-4:00 pm Break
4:00-5:00 pm NK Cells - Lewis Lanier, PhD, University of California, San Francisco
5:00-6:00 pm Reception
Tuesday  February 21
8:00-8:30 am Continental Breakfast
8:30-9:30 am T Cell Subsets  - Andrew Lichtman, MD, PhD, Brigham & Women's Hospital 
9:30-9:45 am Break
9:45-10:45 am T-B Cell Collaboration - Shiv Pillai, MD, PhD, Massachusetts General Hospital
10:45-11:00 am Break
11:00 am-12:00 pm Immune Tolerance and Regulation - Abul Abbas, MD, University of California, San Francisco
12:00-1:30 pm Lunch
1:30-2:30 pm Autoimmunity - Terri Laufer, MD, University of Pennsylvania
2:30-2:45 pm Break
2:45-3:45 pm Tumor Immunity - Catherin Wu, MD, Dana Farber Cancer Institute
3:45-4:00 pm Break
4:00-5:00 pm Transplantation - Jonathan Maltzman, MD, PhD, Stanford University
6:00-8:00 pm Student Dinner with Faculty
Wednesday  February 22
7:30-8:00 am Continental Breakfast
8:00-9:00 am Allergies - Paul Bryce, PhD, Northwestern University
9:00-9:15 am Break
9:15-10:15 am Mucosal Immunity - Richard Blumberg, MD, Brigham & Women's Hospital
10:15-10:30 am Break
10:30-11:30 am Immunodeficiencies - Steve Holland, MD, National Institute of Allergy and Infectious Diseases
11:30-11:45 am Break
11:45 am - 12:45 pm Translational Immunology - Mark Anderson, MD, PhD, University of California, San Francisco


The Federation of Clinical Immunology Societies is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education credits for physicians.

The Federation of Clinical Immunology Societies designates this educational activity for a maximum of 16 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

photo3 photo1 photo2 photo4

Course Testimonials

Read what past attendees are saying about the Advanced course:

  • "An excellent, well-organized and educational course. I thoroughly enjoyed the entire program."
  • "Excellent course at an excellent location and hotel. I am grateful for this opportunity and have learned so much that made every minute worth it."
  • "Excllent course. One of the major strengths: graduation of sessions from initially basic to clinical immunology at the end. A great course for an MD who wants to obtain a stronger immunology background."
  • "Very good course. High quality, excellent speakers, well organized. Highly recommended."
  • "Well respected. Certainly held its excellent reputation as noted at my institution."

Cancellation Policy

For notification of cancellation received in writing by the FOCIS Executive Office before December 30, 2015, a full refund, less a $100 administrative fee, will be given. Cancellation requests received between January 1, 2016 and and January 25, 2016 are eligible for a refund of 50%. No refunds will be provided after January 25, 2016.

Questions? Please contact This email address is being protected from spambots. You need JavaScript enabled to view it.  for more information.